Keyword Connections

doi:10.1007/s40259-018-00331-4

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

1

1 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial